Search Results - "Merat, Shahin"

Refine Results
  1. 1

    Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis by Fadaei, Reza, Poustchi, Hossein, Meshkani, Reza, Moradi, Nariman, Golmohammadi, Taghi, Merat, Shahin

    Published in Scientific reports (03-08-2018)
    “…Non-alcoholic fatty liver disease (NAFLD) is associated with a substantial increased risk of atherosclerotic cardiovascular disease (ASCVD), which is partly…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    An updated systematic review and meta-analysis on efficacy of Sofosbuvir in treating hepatitis C-infected patients with advanced chronic kidney disease by Majd Jabbari, Sara, Maajani, Khadije, Merat, Shahin, Poustchi, Hossein, Sepanlou, Sadaf G

    Published in PloS one (10-02-2021)
    “…Sofosbuvir seems to be a revolutionary treatment for Hepatitis C-infected patients with advanced chronic kidney disease (CKD) but existing evidence is not…”
    Get full text
    Journal Article
  6. 6

    Effect of Enteric-Coated, Delayed-Release Peppermint Oil on Irritable Bowel Syndrome by Merat, Shahin, Khalili, Shadi, Mostajabi, Pardise, Ghorbani, Anahita, Ansari, Reza, Malekzadeh, Reza

    Published in Digestive diseases and sciences (01-05-2010)
    “…Herbal remedies, particularly peppermint, have been reported to be helpful in controlling symptoms of irritable bowel syndrome (IBS). We conducted a randomized…”
    Get full text
    Journal Article
  7. 7

    Assessment of the impact of different fecal storage protocols on the microbiota diversity and composition: a pilot study by Moossavi, Shirin, Engen, Phillip A, Ghanbari, Reza, Green, Stefan J, Naqib, Ankur, Bishehsari, Faraz, Merat, Shahin, Poustchi, Hossein, Keshavarzian, Ali, Malekzadeh, Reza

    Published in BMC microbiology (28-06-2019)
    “…Fecal samples are currently the most commonly studied proxy for gut microbiota. The gold standard of sample handling and storage for microbiota analysis is…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Polypill protects MAFLD patients from cardiovascular events and mortality: a prospective trial by Ramandi, Alireza, George, Jacob, Merat, Shahin, Jafari, Elham, Sharafkhah, Maryam, Radmard, Amir Reza, Nateghi Baygi, Alireza, Delavari, Alireza, Mohammadi, Zahra, Poustchi, Hossein, Malekzadeh, Reza

    Published in Hepatology international (01-08-2023)
    “…Background Metabolic dysfunction-associated fatty liver disease (MAFLD) is a novel term that distinguishes patients at risk of adverse clinical outcomes with…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Seroprevalence of hepatitis C virus: the first population-based study from Iran by Merat, Shahin, Rezvan, Houri, Nouraie, Mehdi, Jafari, Elham, Abolghasemi, Hassan, Radmard, Amir Reza, Zaer-rezaii, Hanieh, Amini-Kafiabad, Sedigheh, Maghsudlu, Mahtab, Pourshams, Akram, Malekzadeh, Reza, Esmaili, Saeed

    “…Summary Objective Early studies on blood donors point to a seroprevalence of approximately 0.25% for hepatitis C virus (HCV) infection in Iran. However, the…”
    Get full text
    Journal Article
  13. 13

    A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting by Hariri, Sanam, Sharafkhah, Maryam, Alavi, Maryam, Roshandel, Gholamreza, Fazel, Abdolreza, Amiriani, Taghi, Motamed-Gorji, Nazgol, Bazazan, Abolfazl, Merat, Shahin, Poustchi, Hossein, Malekzadeh, Reza

    Published in Harm reduction journal (14-08-2020)
    “…Abstract Background Hepatitis C virus (HCV) is among the highest priority diseases in custodial settings; however, the diagnosis remains suboptimal among…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    The Predictive Factors for Favorable Outcomes of Peginterferon and Ribavirin Combination Therapy in HCV-Infected Patients by Moayedi, Javad, Hashempour, Tayebeh, Musavi, Zahra, Dehghani, Behzad, Hasanshahi, Zahra, Merat, Shahin

    Published in Acta medica Iranica (2020)
    “…We aimed to investigate the association of pretreatment host and/or viral related factors with sustained virological response (SVR) rate in chronic hepatitis C…”
    Get full text
    Journal Article
  18. 18

    Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences by Radmard, Amir Reza, Merat, Shahin, Kooraki, Soheil, Ashrafi, Mahya, Keshtkar, Abbas, Sharafkhah, Maryam, Jafari, Elham, Malekzadeh, Reza, Poustchi, Hossein

    Published in Annals of hepatology (01-09-2015)
    “…AbstractBackground. Existing evidence suggests the visceral fat is more metabolically active than subcutaneous fat. We aimed to investigate the value of…”
    Get full text
    Journal Article
  19. 19
  20. 20